Navigation Links
Discovery could help to develop drugs for organ transplant and cancer patients
Date:4/13/2012

MAYWOOD, Ill. -- Loyola researchers are reporting surprising findings about a molecule that helps ramp up the immune system in some cases and suppress it in others.

The finding eventually could lead to new drugs to regulate the immune system by, for example, revving it up to attack tumor cells or tamping it down to prevent the rejection of transplanted organs.

The study is published online ahead of print in the Journal of Immunology. Senior author is Makio Iwashima, PhD, an associate professor in the Department of Microbiology & Immunology of Loyola University Chicago Stritch School of Medicine. Co-authors are Robert Love, MD, a professor in the Departments of Thoracic & Cardiovascular Surgery and Microbiology & Immunology and one of the world's leading lung transplant surgeons, and first author Mariko Takami, PhD, of the Department of Microbiology & Immunology.

The immune system relies on a balancing act between two types of cells. Effector cells attack tumor cells and cells infected by viruses or bacteria. Regulatory cells suppress the immune system so that it does not attack healthy tissue. If effector cells are too active, an individual can suffer autoimmune disorders such as lupus, Type 1 diabetes and multiple sclerosis. But if regulatory cells are too active, the immune system will not be aggressive enough to protect the individual from germs and cancer.

The study involved an immune system molecule called transforming growth factor beta (TGF-β). TGF-β is known to be a powerful regulator of the immune response -- generally suppressing the strength of the response. In this study, however, Loyola researchers demonstrated that TGF-β can amplify the immune response and result in a more effective targeted response under specific conditions.

"TGF-β is a double-edged sword," Iwashima said. "It augments immune system reactions but does not determine what direction they will take. Depending on conditions, these reactions can either activate or suppress the immune system."

The study involved mouse cells grown ex vivo in laboratory dishes. The next steps will be to study TGF-β in human cells and in animal models. Understanding the dual role of TGF-β could help in the development of drugs to either activate or suppress the immune system, as needed, Iwashima said.


'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Related medicine news :

1. Washingtons Life Sciences Discovery Fund awards commercialization grants
2. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
3. New discovery of proteins involved in positioning muscular nuclei
4. Cell signaling discovery provides new hope for blood disorders
5. Gene mutation discovery sparks hope for effective endometriosis screening
6. Discovery predicts patient sensitivity to important drug target in deadly brain cancer
7. Discovery of new vaccine approach for treatment of cancer
8. Zebrafish may help speed drug discovery
9. Unexpected discovery opens up new opportunities for targeting cancer
10. Journal names discovery that HIV treatment can prevent spread breakthrough of the year
11. Salk discovery may lead to safer treatments for asthma, allergies and arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2020)... ... January 09, 2020 , ... Real World Evidence and Data:, ... 2020 • 1:30-3:00 p.m. EST, https://www.centerwatch.com/rweanddata , How can one ... and identify gaps and challenges when conducting trials? The Tufts Center for the ...
(Date:1/7/2020)... ... January 07, 2020 , ... Destressing the patient payment and billing experience, balancing ... are among the topics to be examined at the HFMA Western Symposium, to be ... executive officer for Healthfuse, a leader in supporting hospitals to more effectively source and ...
(Date:1/7/2020)... and LAS VEGAS (PRWEB) , ... January 06, 2020 , ... ... its formation and unveil its first product: The LumaCare Duo ™. , The ... (#44868) in the Sands Convention Center in Las Vegas, Nevada during CES 2020, the ...
(Date:1/7/2020)... ... , ... MMJ International Holdings, the premier medical cannabis research company, recently announced ... and CBD proprietary drug formulation which will be used for the treatment of Huntington’s ... confident that it will bring much needed relief to patients suffering from the debilitating ...
(Date:1/3/2020)... ... January 03, 2020 , ... Liz Barlowe, MA, CMC was ... (ALCA). Aging Life Care Professionals® have advanced degrees and are experts in health ... and work with the family to provide recommendations for needed goods and services ...
Breaking Medicine News(10 mins):
(Date:1/7/2020)... (PRWEB) , ... January 07, 2020 , ... ... first calibration-free blood pressure (BP) sensor system for integration in hearables and wearables. ... device and consumer electronics manufacturers for inclusion in their products. Embedded in an ...
(Date:1/7/2020)... ... 06, 2020 , ... MemoryCare.com , a comprehensive resource ... Memory Care Facilities in Fargo, North Dakota. The guide identifies 2 memory care ... According to the Alzheimer’s Association , 5.6 million people age 65 and ...
(Date:1/7/2020)... ... 07, 2020 , ... China’s NMPA (CFDA):, Latest Regulatory Updates ... EST, https://www.fdanews.com/chinanpma , China is the second-largest medical device and in ... 20 percent annual growth rate year after year. , Stay up to speed ...
Breaking Medicine Technology: